spacer
home > ict > summer 2019 > plan, track, and refine
PUBLICATIONS
International Clinical Trials

Plan, Track, and Refine




‘Eating healthy is easy’. This is a sentiment you are unlikely to hear from someone who is trying to change their eating habits. For most people, eating healthy requires a plan, the discipline, and the willingness to adapt to changing circumstances. Put simply, a great deal of thought and effort are required to see real and consistent results. Similarly, ‘managing enrolment is easy’ is not something you are likely to hear from a sponsor who has had issues in the past or is heading into a new therapeutic area. Much like eating healthy, enrolment requires sponsors and CROs to develop, track, and continually refine a plan to hit their targets and ensure the health of their trial.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Mark Springer has over 20 years of clinical operations expertise, with a focus on trial and project management and recruitment and retention enhancements, as well as driving the adoption of new innovation through change management. Within the Consultative Services group, Mark is the lead Subject Matter Expert for the trial optimiser services, which includes StudyOptimizer. Together, these are tools that help study teams plan, track, diagnose, and optimise patient enrolment.


Print this page
Send to a friend
Privacy statement
News and Press Releases

IATA CEIV Pharma certificate of Turkish Cargo renewed

Turkish Cargo, the air cargo brand flying to the most countries around the world, extended the validity period of its IATA CEIV (Center of Excellence for Independent Validators) Pharma certificate to 2022, proving its success in all processes throughout the air transportation of medicinal products.
More info >>

White Papers

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>

 
Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement